Friday, Sep 29, 2023
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Education Today
    • Reviews
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | India | Zydus Cadila Gets Dgci Nod For Phase 3 Clinical Trials With Biological Therapy

Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapy

The trials, which will commence in December, will be conducted on 250 patients across 20-25 centres in India.

By PTI
Published Date - 12:59 PM, Fri - 4 December 20
Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapy
whatsapp facebook twitter telegram

New Delhi: Drug firm Zydus Cadila on Friday said it has received the approval from the Drugs Controller General of India (DCGI) to start phase 3 clinical trials with its biological therapy PegiHep in COVID-19 patients.

The company had completed the phase 2 clinical trials with PegiHep last month.

In a regulatory filing, Zydus Cadila said it has received approval from the DCGI to start the phase 3 clinical trials in COVID-19 patients with its biological therapy Pegylated Interferon alpha-2b or PegiHep.

The trials, which will commence in December, will be conducted on 250 patients across 20-25 centres in India, according to the filing.

Sharvil Patel, Managing Director of Cadila Healthcare Ltd, said, “we are encouraged by the results of phase 2 study of Pegylated Interferon alpha 2-b which has shown the potential to reduce virus titres when given earlier in the disease”.

“Our efforts are to look at possible treatment options to fight COVID-19 which are safe, can be administered easily and also reduce the disease burden”.

Further, the company said it is conducting a similar phase 2 trial in Mexico and is also working with the US Food and Drug Administration (USFDA) to open an Investigational New Drug (IND) application for PegiHep in order to initiate appropriate clinical trials in the US.

Telangana Today Whatsapp
  • Follow Us :
  • Tags
  • clinical trials
  • Corona Virus Deaths
  • Coronavirus
  • Coronavirus in India

Related News

  • Wife’s efforts to meet expenses no ground to reduce maintenance amount by husband: Delhi HC

    Wife’s efforts to meet expenses no ground to reduce maintenance amount by husband: Delhi HC

  • AI, blood biomarker spots long Covid patients with 96% accuracy

    AI, blood biomarker spots long Covid patients with 96% accuracy

  • True long Covid risk likely ‘exaggerated’, says global study

    True long Covid risk likely ‘exaggerated’, says global study

  • China propels Apple’s growth in last 9 years, net sales up by 128%: Report

    China propels Apple’s growth in last 9 years, net sales up by 128%: Report

  • Memorial for journalists killed during COVID-19 to be inaugurated on October 2

    Memorial for journalists killed during COVID-19 to be inaugurated on October 2

  • China’s ‘batwoman’ claims outbreak of new SARS-like pandemic ‘highly likely’

    China’s ‘batwoman’ claims outbreak of new SARS-like pandemic ‘highly likely’

Latest News

  • Senior CGST official in UP duped of Rs 40K in online fraud

    7 mins ago
  • Ramanathan and Myneni secure Asian Games Men’s Doubles Silver

    6 mins ago
  • Karnataka Bandh: Bengaluru police detain members of pro-Kannada organisations

    18 mins ago
  • Tea vendor scalds teen with hot tea, sparks communal tension in Kanpur

    21 mins ago
  • Such persons have no place in society, will ensure strict punishment: Chouhan on Ujjain rape accused

    27 mins ago
  • Pentagon’s strategy document calls North Korea ‘persistent threat’

    38 mins ago
  • Uttar Pradesh: Teacher arrested for asking muslim student to slap hindu classmate

    21 mins ago
  • Asian Games: Indian race-walkers fail to secure medals in 20 km event

    47 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam